According to UAB research published in Retina, it has been found that a drug, which is used to treat colorectal cancer, was find equally effective in treating cystoid macular edema (CME), a common complication of cataract surgery.
The researchers report on two patients with severe retinal swelling who were not candidates for steroid therapy, the typical treatment. "Bevacizumab, or Avastin, works in colorectal cancer by inhibiting the blood supply," said John Mason, M.D., assistant professor of ophthalmology.
"Our CME patients had severe vision loss but responded well to Avastin. Swelling was reduced and visual acuity dramatically improved." Mason added that Avastin also might be beneficial for patients with macular degeneration.